Report

Enhanced Morphine Analgesia in Mice Lacking β-Arrestin 2

Science  24 Dec 1999:
Vol. 286, Issue 5449, pp. 2495-2498
DOI: 10.1126/science.286.5449.2495

You are currently viewing the abstract.

View Full Text

Via your Institution

Log in through your institution

Log in through your institution


Abstract

The ability of morphine to alleviate pain is mediated through a heterotrimeric guanine nucleotide binding protein (G protein)–coupled heptahelical receptor (GPCR), the μ opioid receptor (μOR). The efficiency of GPCR signaling is tightly regulated and ultimately limited by the coordinated phosphorylation of the receptors by specific GPCR kinases and the subsequent interaction of the phosphorylated receptors with β-arrestin 1 and β-arrestin 2. Functional deletion of the β-arrestin 2 gene in mice resulted in remarkable potentiation and prolongation of the analgesic effect of morphine, suggesting that μOR desensitization was impaired. These results provide evidence in vivo for the physiological importance of β-arrestin 2 in regulating the function of a specific GPCR, the μOR. Moreover, they suggest that inhibition of β-arrestin 2 function might lead to enhanced analgesic effectiveness of morphine and provide potential new avenues for the study and treatment of pain, narcotic tolerance, and dependence.

  • * These authors contributed equally to this report.

  • To whom correspondence should be addressed. E-mail: lefko001{at}receptor-biol.duke.edu; or caron002{at}mc.duke.edu

  • To whom requests for materials should be addressed.

View Full Text

Related Content